This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$38.74
US$ Class I Dist
NAV per share 04.03.2021
£970.0mAUM

AUM 29.01.2021

Holdings
70.01% Active Share
As at 29.01.2021